Testing the Effectiveness of an Anti-cancer Drug, Triapine, When Used With Targeted Radiation-based Treatment (Lutetium Lu 177 Dotatate), Compared to Lutetium Lu 177 Dotatate Alone for Metastatic Neuroendocrine Tumors

NCT05724108 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

94

Enrollment

NIH

Sponsor class

Conditions

Metastatic Neuroendocrine Tumor

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Computed Tomography
DRUG: Lutetium Lu 177 Dotatate
PROCEDURE: Magnetic Resonance Imaging
DRUG: Triapine

Sponsor

National Cancer Institute (NCI)